Theravance Biopharma, Inc.

Healthcare · Biotechnology · United States

Last price 17.03 USD (At close: Sep 23, 2026) · Market cap 884.18M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. fo...